DALLAS, June 1, 2024 /PRNewswire/ -- STEMREGENⓇ, the trailblazer in stem cell science-backed supplements that support the body's innate repair system, is proud to announce that they'll be returning for a second year in a row as title sponsor for the 2025 Biohacking Conference, hosted by Dave Asprey, the Father of Biohacking.
The news was jointly... (continue reading...)
CHICAGO, June 1, 2024 /PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for two of its products have been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The company will showcase the latest clinical trial findings for IMC001 in a poster presentation and for IMC002 in an online presentation during... (continue reading...)
Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient Mismatched Repair Status (pMMR) TP53 Wild-Type Exploratory Subgroups
Q-TWiST, an Important Metric Assessing Both Quality and Quantity of Clinical Benefit, Suggests Improvement with Selinexor versus Placebo, which is Critical in the Maintenance Setting
Company... (continue reading...)
GUANGZHOU, China, May 31, 2024 /PRNewswire/ -- A news report from GDToday:
Organized by the Guangdong Government, the Government of the State of California, Chinese People's for Friendship with Foreign Countries and California China Climate Institute, the first US-China Bay to Bay Dialogue was held in Berkeley, California on May 29 (local time).
More than 200 representatives from both sides attended the Dialogue, including Guangdong... (continue reading...)
VANCOUVER, BC, June 1, 2024 /PRNewswire/ - Taseko Mines Limited (TSX: TKO) (NYSE MKT: TGB) (LSE: TKO) ("Taseko" or the "Company") announced today that operations at the Company's Gibraltar Mine have been suspended.
Collective bargaining with Gibraltar's union representatives has been ongoing in recent weeks, and ended late yesterday without an agreement being reached. Gibraltar's unionized workforce informed the Company that they intended to take strike action as... (continue reading...)
More PRNewswire
View Older Stories-
PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
-
Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
-
ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
-
Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
-
Vincent Todd Announces the Introduction of Todd Agriscience
-
Hyundai Motor America Reports May 2024 Sales
-
Beverly Hills MD Celebrates Its 10th Anniversary
-
American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
-
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
-
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
-
James Avery Artisan Jewelry Opens New Store at Westover Marketplace
-
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
-
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
-
BALEAF & SOJOS to host "Summer it up" summer fashion extravaganza!
-
Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients
-
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemo
-
ZEEKR Announces May 2024 Delivery Update
-
ALL-TIME BEST MONTHLY SALES FOR THE KIA EV9 AND SPORTAGE SUVs LEAD KIA AMERICA TO SECOND BEST SALES MONTH IN COMPANY HISTORY IN MAY
-
'A Fu, the hutong gentleman'
-
HTX Ventures Invests in Babylon to Advance Trustless Bitcoin Staking
-
Skymizer Launches Groundbreaking LLM Accelerator IP for on-device LLM Inferencing, EdgeThought, the game-changer in on-device GenAI era.
-
Vivacelle Bio's President and Chief Innovation Officer to Present Data Highlighting the Company's Late-Stage Clinical Programs at the BIO International Convention 2024
-
Hamamatsu Photonics completes the acquisition of NKT Photonics A/S
-
Discover the World expands relationship with South African Airways adding Key European Markets
-
West Fraser Releases 2023 Sustainability Report
-
Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders
-
Babyganics and Nikki Reed Launch 'Oops! I Forgot It Again' To Help Parents Prepare for Summer
-
AZORES AIRLINES OFFERS NEW ROUTES STARTING IN JUNE
-
Local Middle School Students win $5,000 Game Creator Scholarship--to be presented on June 3rd at Eckstein Middle School
-
Oi S.A. - Em Recuperação Judicial Announces Launch of Restructuring Plan Subscription and Option Election Process
-
RECOMMENDED CASH OFFER for MARIADB PLC by MERIDIAN BIDCO LLC ("Bidco") which is an Affiliate of K1 INVESTMENT MANAGEMENT, LLC ("K1") as manager of K5 PRIVATE INVESTORS, L.P.
-
Rally House Opens 20th Store in Philadelphia
-
Rally House Reaches a Dozen Store Locations in Indiana
-
NASA Awards Advance Technologies for Future Habitable Worlds Mission
-
UFC GYM PITTSBURGH CELEBRATES ONE-YEAR ANNIVERSARY OF FITNESS FOR EVERY BODY WITH WEEKLONG FREE OPEN HOUSE DOWNTOWN
-
Rally House Opens Wrigleyville Location
-
Gogoro Announces Results of Annual General Meeting of Shareholders
-
INTERNATIONAL BATTERY METALS LTD. ANNOUNCES SUBSEQUENT CLOSING OF STRATEGIC PRIVATE PLACEMENT
-
Book Aleutian Airways Flights on AlaskaAir.com and Earn Alaska Airlines Miles
-
The Asian American Foundation's 3rd Annual Heritage Heroes Special Premieres on Prime Video
-
GoDaddy Inc. Completes Refinancing and Extension of Existing Tranche B-4 Term Loans and Certain Tranche B-6 Term Loans
-
redT Homes Honored as Best Individual Electric Only Builder Overall in 2023 Xcel ESNH Program
-
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related reactions with five-minute subcutaneous amivantamab administration
-
Streamlining Contract Management: Info-Tech Research Group Publishes Guide to CLM Process Efficiency
-
Lumina Gold Announces US$10.2 million Wheaton Precious Metals Draw and Amendment to the PMPA
-
BRP ANNOUNCES ELECTION OF DIRECTORS AND BOARD COMMITTEE COMPOSITION
-
Steritech and MenuTrinfo® Partner to Enhance Food Allergy Safety with AllerCheck™ Assessments
-
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer progression-free survival versus osimertinib in first-line treatment of patients with high-risk EGFR
-
INOVIO Reports Inducement Grants Under Inducement Plan
-
LAZ Enters Canadian Market With Contract to Manage Parking Services at Edmonton International Airport
